POS-281 Prognostic Significance of Erythropoiesis-Stimulating Agent Dose Requirements in PIVOTAL and its Implications for the Potential Mechanisms of IV Iron Benefit in Maintenance Haemodialysis Patients

POS-281 Prognostic Significance of Erythropoiesis-Stimulating Agent Dose Requirements in PIVOTAL and its Implications for the Potential Mechanisms of IV Iron Benefit in Maintenance Haemodialysis Patients

Bibliographic Details
Main Authors: B. Oliveira, F.M. Barakat, M. Robertson, I. Ford, C.I. Macdougall, D. Okonko
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024921004423

Internet

http://www.sciencedirect.com/science/article/pii/S2468024921004423

Similar Items